Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piracetam for Tardive Dyskinesia
NCT00190008Phase 3Completed
- Sponsor
- Be'er Sheva Mental Health Center
- Start
- Aug 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of piracetam in tardive dyskinesia (TD) (2 arms), sponsored by Be'er Sheva Mental Health Center. Primary endpoint: Extrapyramidal Symptom Rating Scale. Started Aug 2003; status: completed.
02
Drugs
piracetam
03
Conditions
tardive dyskinesia (TD)
Beyond the preview
Go deeper on NCT00190008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00190008.